| Stenosis of pulmonary artery |
Pulmonary artery stenosis (PAS) is a narrowing of the pulmonary artery. The pulmonary artery is a blood vessel moving blood from the right side of the heart to the lungs. This narrowing can be due to many causes, including infection during pregnancy, a congenital heart defect, a problem with blood clotting in childhood or early adulthood, or a genetic change.
The narrowing can occur at many points along the pulmonary artery. The specific location indicates severity and affects treatment options. Most people with high-risk PAS are neonates, newborns, and young children. The more severe the disease the more likely it is to present with symptoms. With high-risk patients, it is necessary and acceptable to actively treat, to avoid worsening blood pressure, poor heart function, and worsening vessel disease across the body.[1]
Blood flows in a methodical way through the body. Blood that has already delivered oxygen returns to the heart. It arrives at the right upper chamber, gets pumped though the tricuspid valve and into the lower right chamber. It travels through the pulmonary valve to the pulmonary artery and toward the lungs. Oxygenated blood returns to the left side of the heart before it is pumped throughout the body.[2] When the pulmonary artery narrows, it increases blood pressure on the right side of the heart and causes the heart to work harder.[3]
PAS is not the same as pulmonary valve stenosis. The pulmonary valve is the opening between the right heart and the pulmonary artery. Valve narrowing has similar effects. However, treatment is different. The long term consequences of each condition also vary and present with other comorbidities.[4]
Pulmonary artery stenosis symptoms depend on the location and cause of the narrowing. Common symptoms include:[5]
Other symptoms are caused by lack of oxygenated blood flow. This causes individuals to present with:
When blood cannot reach the lungs because of the narrowing, blood can back up. This can lead to swelling in body parts such as the hands and feet and can present similarly to right sided heart failure.
Although 40% of individuals have no other underlying heart problems, PAS can still occur in 2-3% of individuals with congenital heart disease:
Genetic and infectious conditions:
There is no immediate way to know if a child has PAS, but abnormal heart sounds, also known as murmurs, heard on physical exam, dictate further testing.
The three treatments are balloon angioplasty, cutting balloon angioplasty, and stenting.
Balloon angioplasty expands the diameter of a vessel to counter narrowing. In this treatment a catheter with a balloon on the end is inserted into a larger, peripheral vessel and moved to the narrowing site. The goal is to tear two of the three layers of the artery, which increases the vessel's diameter and blood flow. A relatively stiff balloon achieves 72% efficacy with no risk increase.
After the procedure is performed, several factors help determine success. These are:
The major reasons for simple balloon angioplasty failure are inability to tear the vessel wall, restenosis, and areas of narrowing due to compression by another body part rather than issues with the vessel itself. Even given evidence of vessel wall tearing, the rate of restenosis is between 15 and 44%. Studies reported that the rate of restenosis increases as time from the procedure increases. Rates of complications overall are estimated around 22%, including 10% higher risk complications. Other complications from this procedure are likely from too much vessel damage and include full vessel tears, deep vein thrombosis (clot in the vessel), complete artery rupture, and pulmonary edema.
Younger patients are typically treated with balloon angioplasty until they are older and the risk for metal stents is significantly reduced.
Cutting balloon angioplasty was invented to help reduce vessel damage. This method utilizes balloons with a blade that can cut through vessel walls rather than simply causing vessel wall tearing via crushing/expansion of the balloon. When the balloon is not inflated the blades are protected inside the balloon folds, ensuring they will not accidentally damage other vessels. After the use of the cutting balloon, a larger, higher-pressure balloon can be used to improve efficacy. Multicenter studies reported the same safety profiles for simple versus cutting, with adverse effect rates of 2% and 3%, respectively. When a high-pressure balloon was used after cutting balloon angioplasty the rate of effectiveness increased from 52% to 85%. Cutting balloon angioplasty provides more areas of vessel damage especially in vessels further from the heart. Overall cutting balloon angioplasty has similar complications and restenosis rates as simple, but offers a more effective treatment, and is a better option for smaller areas.
To solve restenosis and external compression, metal stents were introduced. These stents are deployed via catheter. They are expanded at the site. The stents form a rigid structure that remain at the site. Newer studies reported successful dilation in 90% of patients on average, with newer studies indicating a 100% success rate. The benefits of stents is long term efficacy and the prevention of long term heart disease. Stents improved right side heart pressures, blood flow to the lungs, and pressure difference between the right and left sides. Stents can last up to 15 years, much longer than balloon angioplasty. Stents have the lowest rate of restenosis, at 2-3%.
Stents allow for normal vessel growth during childhood and adolescent years, and do not damage the heart or vasculature. 30-50% of young children required replacement with a larger stent in the first 2 years of placement. Complication rates are around 12% and include drift due to blood flow, which can damage vessels, clot formation on the stent. Because of these concerns and necessary removal of the stent if these were to occur, the stent must be monitored frequently after placement.
Another concern is fracturing, or breaking, due to repetitive pressure. Patients experience a 13% adverse event rate with major events such as a fracture at 1.2%. Studies reported that the adverse event rate decreased with patient age, likely due to less growth in the vessel. Replacement rates are as high as 43%, and increases over time.
Prior to the development of balloon angioplasty, surgical angioplasty was the main treatment method. Because of lack of efficacy, limited accessibility to certain areas of stenosis, increased risk for scarring, and a high rate of repeat stenosis, surgical angioplasty is only used if other methods fail or if surgeons observe the narrowing while repairing another defect. Some studies reported a 62% surgical success rate for surgical angioplasty. Alternative treatments would be required for 4/10 patients while exposing them to risks of surgery.
Initially a soft balloon was used, but only about 60% of patients experienced even a 50% increase in blood flow. This efficacy was similar to surgical angioplasty with a large risk reduction. Later, a stiffer balloon achieved better results,